WEST PHARMACEUTICAL SERVICES overview

West to Host First-Quarter 2025 Conference Call PR Newswire EXTON, Pa., April 10, 2025 EXTON, Pa. , April 10, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 24, 2025 , and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time . The...

West to Participate in Upcoming Investor Conferences PR Newswire EXTON, Pa., March 5, 2025 EXTON, Pa. , March 5, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025 at 11:00 AM ET . It will also present at the KBCM Healthcare Forum on Wednesday, March 19, 2025 at 1:30 PM ET. A live...

West Announces Second-Quarter Dividend PR Newswire EXTON, Pa., Feb. 20, 2025 EXTON, Pa. , Feb. 20 , 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2025 dividend of $0.21 per share. The dividend will be paid on May 7, 2025 , to shareholders of record as of April 30, 2025 . About West West Pharmaceutical Services, Inc....

West Announces Fourth-Quarter and Full-Year 2024 Results PR Newswire EXTON, Pa., Feb. 13, 2025 - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Feb. 13, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024 and introduced 2025 financial guidance. Fourth-Quarter Summary (comparisons to prior-year period) & Full-Year 2025 Guidance Fourth-quarter 2024 net sales of $748.8 million increased...

West to Host Fourth-Quarter and Full-Year 2024 Conference Call PR Newswire EXTON, Pa., Jan. 30, 2025 EXTON, Pa. , Jan. 30 , 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2024 financial results before the market opens on Thursday, February 13, 2025, and will follow with a conference call to discuss the results and business expectations...

West Announces First-Quarter Dividend PR Newswire EXTON, Pa., Jan. 28, 2025 EXTON, Pa. , Jan. 28, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2025 dividend of $0.21 per share. The dividend will be paid on February 11, 2025, to shareholders of record as of February 7, 2025. About West West Pharmaceutical Services,...

West Introduces Daikyo PLASCAP® RUV Closures in New Nested Format at Pharmapack PR Newswire EXTON, Pa., Jan. 22, 2025 EXTON, Pa. , Jan. 22, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the introduction of Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures in a new nested format available in multiple configurations at this year's Pharmapack event in Paris , France. This marks...

West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference PR Newswire EXTON, Pa., Jan. 6, 2025 EXTON, Pa. , Jan. 6, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that Cindy Reiss-Clark , Sr. VP and Chief Commercial Officer; Chad Winters , VP of Finance and Chief Accounting Officer; and John Sweeney , VP of Investor Relations,...